Broker notes, analysis and comments
Vertu Motors Plc (LON:VTU) has reported another record performance for H1 2018, with adjusted EPS +5% ahead of our expectations. We maintain our FY 2018 assumptions at this juncture but..
Allergy Therapeutics Plc (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. Pollinex Quattro continues to gain market share despite being available in the EU only..
The 1Q trading update from City of London Investment Group Plc (LON:CLIG), a leading specialist asset management group focused on emerging markets and closed-end funds, reveals: 1Q rise of 6%..
Motorpoint Group Plc (LON:MOTR) has released a trading update this morning confirming a solid H1 performance with over 18% revenue growth. While we recognise there is an element of consumer..
ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are..
MelodyVR, the leading creator of virtual reality content focused on the music industry and subsidiary of EVR Holdings Plc (LON:EVR), this morning announces that it has entered into a VR..
A recent visit to Avanco Resources Limited (ASX:AVB) projects in northern Brazil confirmed our belief that the group’s portfolio has significant growth potential, and that the company has a management..
Scancell Holdings Plc (LON:SCLP) is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates high avidity..
Advanced Oncotherapy Plc (LON:AVO) is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an..
In 2016 Sinclair Pharma Plc (LON:SPH) was transformed into a streamlined, pure-play aesthetics company with a concentrated, competitive portfolio of differentiated injectable products. Effective, longer-lasting, natural looking, minimally invasive treatments..
ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are..
Purplebrick Group Plc (LON:PURP) AGM trading update confirms that it has made a “strong start” to the current financial year to 30 April 2018 and “trading in the UK and..
Gym Group Plc (LON:GYM) Valuing high growth companies can be tricky. The cost of establishing growth tends to drag down current earnings, making the company look expensive on straight PE..
Abzena Plc (LON:ABZA) is a global life sciences group offering a broad range of integrated services and technologies to enable the development of better biopharmaceutical drugs. With strong footprints in..
EVR Holdings plc (LON:EVR) Virtual Reality devices provide consumers with access to fully immersive 3D worlds, as well as the ability to interact within a virtual environment as if they..
Harvey Nash Group Plc (LON:HVN) has delivered a robust set of H1 results, with adjusted EPS +17% YOY. The underlying business is performing to plan, albeit market conditions across its..
boohoo.com Plc (LON:BOO) continues to exceed expectations, delivering H1 group revenue growth of 106% to £262.9m, with boohoo brand up 43% YoY (40% CER) and PLT delivering standout growth of..
STRIX GROUP PLC ORD 1P (LON:KETL) is the global leader in the manufacture of kettle safety controls with a market share by value of over 50%. Its controls are used..
FY17 was yet another year of progress for MySale Group plc (LON:MYSL), with sustained focus on the strategic goals achieving growth in both revenue and profitability. FY revenue increased by..
Global Yachting Group – GYG Plc (LON:GYG) has delivered a robust set of H1 forecasts, which are marginally ahead of our (Zeus Capital) forecast given in our recent initiation note..
